Skip to main content
ROSSARI BIOTECH LIMITED logo

ROSSARI BIOTECH LIMITED — Investor Relations & Filings

Ticker · ROSSARI ISIN · INE02A801020 LEI · 335800R7XFRR8ZTHBQ25 BSE.NS Manufacturing
Open in API
Filings indexed 529 across all filing types
Latest filing 2023-09-29 Regulatory Filings
Country IN India
Listing BSE.NS ROSSARI

About ROSSARI BIOTECH LIMITED

https://www.rossari.com/

Rossari Biotech Limited is a specialty chemicals manufacturer focused on providing sustainable and innovative solutions across diverse sectors. The company operates through three primary business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals, and Animal Health and Nutrition. In the HPPC segment, it supplies essential ingredients for detergents, soaps, paints, and water treatment applications. Its textile division offers a comprehensive range of chemicals for the entire textile value chain, including pre-treatment, dyeing, and finishing processes. Additionally, the company provides high-quality feed additives and supplements for the poultry and livestock industries. Driven by robust research and development capabilities, Rossari Biotech emphasizes eco-friendly chemistry and customized formulations to meet specific client requirements. With advanced manufacturing facilities, the company serves a global clientele, maintaining a strong focus on operational excellence.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 100% confidence The document text is extremely short (80 characters) and contains only a digital signature with a date. There is no substantive content, financial data, or report information. It does not contain any report, announcement, or detailed filing information. Given the lack of content, this is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2023-09-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document text is mostly unreadable or corrupted, containing mostly non-standard characters and no clear content. There are no identifiable keywords, regulatory references, fiscal period dates, or document titles that can help classify the document. The length is 1793 characters, which is quite short and suggests it might be an announcement or a brief notice rather than a full report. Given the lack of meaningful content and the short length, the best fit classification is Regulatory Filings (RNS), which serves as a fallback category for miscellaneous filings that do not fit other categories.
2023-08-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call for Rossari Biotech Limited for Q1 FY24, dated July 31, 2023. It includes management's opening remarks, financial performance details with specific figures for revenue, EBITDA, and PAT, strategic updates such as acquisitions and ERP implementation, and a Q&A session with analysts discussing business segments and financial metrics. The presence of detailed financial data, management commentary, and Q&A indicates this is a full transcript of an earnings call rather than a brief earnings release or presentation. Therefore, the document fits the definition of a Call Transcript (CT).
2023-08-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is extremely short (296 characters) and contains no substantive text or financial data, only references to omitted pictures and a digital signature. There is no indication of any report content, financial statements, or detailed information. This matches the pattern of a very brief filing, likely a certification or a minimal regulatory notice without substantive report data. According to the rules, such documents should be classified as Regulatory Filings (RNS) as a fallback category.
2023-07-31 English
Copy of Newspaper Publication
Regulatory Filings Classification · 90% confidence The document text is largely unreadable or corrupted, with many non-standard characters and missing meaningful content. There is no clear indication of a specific report type such as Annual Report, Interim Report, Earnings Release, or any other defined filing category. The text does not contain any recognizable financial data, regulatory references, or report titles. Given the lack of substantive content and the presence of what appears to be a corrupted or incomplete document, the best classification is Regulatory Filings (RNS), which serves as a fallback category for miscellaneous filings that do not fit other specific categories.
2023-07-31 English
Investor Presentation
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Rossari Biotech Limited Q1 FY24 Results Presentation July 29, 2023' and contains detailed financial data including revenue, EBITDA, PAT, segment-wise revenue, and management commentary. It includes consolidated financial statements and operational discussions for the quarter ended Q1 FY24. The content is typical of a quarterly earnings presentation, providing key financial highlights, management messages, and segment analysis. The length is about 15,000 characters, indicating a full presentation rather than a brief announcement. There is no indication that this is a full annual report (10-K) or an audit report. It is not a transcript of a call, but a presentation document. Therefore, the document fits best into the category of an Interim / Quarterly Report (IR). Q1 2024
2023-07-29 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.